Literature DB >> 23595832

Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States.

Sema Mandal1, Henry M Wu, Jessica R MacNeil, Kimberly Machesky, Jocelyn Garcia, Brian D Plikaytis, Kim Quinn, Larry King, Susanna E Schmink, Xin Wang, Leonard W Mayer, Thomas A Clark, James R Gaskell, Nancy E Messonnier, Mary DiOrio, Amanda C Cohn.   

Abstract

BACKGROUND: College students living in residential halls are at increased risk of meningococcal disease. Unlike that for serogroups prevented by quadrivalent meningococcal vaccines, public health response to outbreaks of serogroup B meningococcal disease is limited by lack of a US licensed vaccine.
METHODS: In March 2010, we investigated a prolonged outbreak of serogroup B disease associated with a university. In addition to case ascertainment, molecular typing of isolates was performed to characterize the outbreak. We conducted a matched case-control study to examine risk factors for serogroup B disease. Five controls per case, matched by college year, were randomly selected. Participants completed a risk factor questionnaire. Data were analyzed using conditional logistic regression.
RESULTS: Between January 2008 and November 2010, we identified 13 meningococcal disease cases (7 confirmed, 4 probable, and 2 suspected) involving 10 university students and 3 university-linked persons. One student died. Ten cases were determined to be serogroup B. Isolates from 6 confirmed cases had an indistinguishable pulsed-field gel electrophoresis pattern and belonged to sequence type 269, clonal complex 269. Factors significantly associated with disease were Greek society membership (matched odds ratio [mOR], 15.0; P = .03), >1 kissing partner (mOR, 13.66; P = .03), and attending bars (mOR, 8.06; P = .04).
CONCLUSIONS: The outbreak was associated with a novel serogroup B strain (CC269) and risk factors were indicative of increased social mixing. Control measures were appropriate but limited by lack of vaccine. Understanding serogroup B transmission in college and other settings will help inform use of serogroup B vaccines currently under consideration for licensure.

Entities:  

Keywords:  meningococcal disease; outbreak; risk factors; serogroup B; university

Mesh:

Year:  2013        PMID: 23595832     DOI: 10.1093/cid/cit243

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  19 in total

1.  Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults.

Authors:  Monica Konar; Dan M Granoff
Journal:  Blood       Date:  2017-06-19       Impact factor: 22.113

2.  Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College-Rhode Island, 2015-2016.

Authors:  Heidi M Soeters; Melissa Whaley; Nicole Alexander-Scott; Koren V Kanadanian; Jessica R MacNeil; Stacey W Martin; Lucy A McNamara; Kenneth Sicard; Cynthia Vanner; Jeni Vuong; Xin Wang; Utpala Bandy; Manisha Patel
Journal:  Clin Infect Dis       Date:  2017-04-15       Impact factor: 9.079

3.  Meningococcal carriage among a university student population - United States, 2015.

Authors:  Lucy Breakwell; Melissa Whaley; Unab I Khan; Utpala Bandy; Nicole Alexander-Scott; Lynn Dupont; Cindy Vanner; How-Yi Chang; Jeni T Vuong; Stacey Martin; Jessica R MacNeil; Xin Wang; Sarah A Meyer
Journal:  Vaccine       Date:  2017-11-26       Impact factor: 3.641

4.  Serum Bactericidal Antibody Responses of Students Immunized With a Meningococcal Serogroup B Vaccine in Response to an Outbreak on a University Campus.

Authors:  Eduardo Lujan; Kathleen Winter; Jillandra Rovaris; Qin Liu; Dan M Granoff
Journal:  Clin Infect Dis       Date:  2017-10-01       Impact factor: 9.079

5.  Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B Meningococci.

Authors:  Serena Giuntini; Eduardo Lujan; Malick M Gibani; Christina Dold; Christine S Rollier; Andrew J Pollard; Dan M Granoff
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

Review 6.  Invasive meningococcal disease in the 21st century—an update for the clinician.

Authors:  Rachel Dwilow; Sergio Fanella
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

7.  Letter to the editor.

Authors:  Raymond Sw Tsang; Frances B Jamieson; Brigitte Lefebvre; Rodica Gilca
Journal:  Can J Infect Dis Med Microbiol       Date:  2014       Impact factor: 2.471

Review 8.  Meningococcal disease and vaccination in college students.

Authors:  Sarah Schaffer DeRoo; Rachel G Torres; Linda Y Fu
Journal:  Hum Vaccin Immunother       Date:  2021-10-06       Impact factor: 4.526

9.  Breadth and Duration of Meningococcal Serum Bactericidal Activity in Health Care Workers and Microbiologists Immunized with the MenB-FHbp Vaccine.

Authors:  Eduardo Lujan; Elizabeth Partridge; Serena Giuntini; Sanjay Ram; Dan M Granoff
Journal:  Clin Vaccine Immunol       Date:  2017-08-04

10.  A cluster of invasive meningococcal disease revealed by the characterization of a novel serogroup B meningococcal clone.

Authors:  L Valinsky; J Jaffe; N Keller; C Block; N Abramson; C Stein-Zamir
Journal:  Epidemiol Infect       Date:  2015-06-26       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.